India to Pakistan: Serum Export Trade Route

The India to Pakistan Serum corridor is one of India's established pharmaceutical export routes, with 29 shipments documented worth a combined $1.4M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's serum manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $49.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with serum's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 14.7%, placing it at rank #16 among India's top serum export destinations globally.

On the import side, key buyers of Indian serum in Pakistan include HABIB BANK LIMITED, BANK ALHABIB LIMITED, ASKARI BANK LIMITED and 8 others. HABIB BANK LIMITED is the single largest importer with 13 shipments valued at $694.0K USD.

India's serum exports to Pakistan are driven primarily by a handful of large-scale manufacturers. BHARAT SERUMS AND VACCINES LIMITED with 13 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Pakistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, PREMIUM SERUMS AND VACCINES PRIVATE LIMITED, PREMIUM SERUMS VACCINES PRIVATE LIMITED — together account for 84% of total trade value on this route. The average shipment value of $49.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical raw material polyvalent anti snake venom serum bulk and snake venom antiserum lyophilized, suggesting that buyers in Pakistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, HABIB BANK LIMITED is the largest importer with 13 shipments worth $694.0K USD — representing 48% of all serum imports from India on this route. A total of 11 buyers are active on this corridor.